BioNTech aims for 2 billion COVID-19 vaccine doses in 2021

Reuters|
PrintFind an error? Report us
German COVID-19 vaccine maker BioNTech, partner of U.S. pharmaceutical group Pfizer, said on Monday it aims to produce two billion doses of its vaccine this year.
"We now believe that we can potentially deliver approximately 2 billion doses in total by the end of 2021, which incorporates the updated 6-dose label," BioNTech said in a presentation.
Comments
The commenter agrees to the privacy policy of Ynet News and agrees not to submit comments that violate the terms of use, including incitement, libel and expressions that exceed the accepted norms of freedom of speech.
""